Single Jab Fights Testicular Cancer
Posted on: Saturday, 23 July 2005, 06:00 CDT
A SINGLE injection of a drug for testicular cancer patients is as effective as two to three weeks of radiotherapy, researchers announced yesterday.
The nine-year study, published in medical journal The Lancet, compared 1,500 patients given a single dose of carboplatin with those who had weeks of daily radiotherapy after their cancerous testicle had been removed.
The researchers said the drug could become the preferred treatment for the most common testicular cancer type, with the prospect of fewer side-effects.
The international study - led by Professor Tim Oliver from Bart's in London and Professor Malcolm Mason from the University of Wales - also found that the patients injected with carboplatin needed less time off work than those who had radiotherapy.
Around 2,000 men are found to have testicular cancer in the UK and Ireland each year. The majority are diagnosed when the cancer is confined to the testis - stage 1 disease - and the standard treatment is to remove the cancerous testicle.
Radiotherapy is effective in preventing cancer returning, but side-effects include temporary infertility, and increased risk of other cancers.
Medical Research Council senior statistician Sally Stenning said: "These results are extremely encouraging."
Source: Daily Mirror
Related Articles
- Boehringer Ingelheim to Commence Phase III Study Investigating the Role of BIBW 2992 as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Mutations
- Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program
- First Coast Oncology Offers First and Only AccuBoost Breast Cancer Radiotherapy Procedure in Northeast Florida; Breakthrough Technology Precisely Delivers Crucial 'Boost' Phase of Therapy
- Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
- Aradigm Announces Data Showing No Occurrence of Primary Lung Cancer in Patients Treated With AERx(R) Insulin Diabetes Management System (iDMS)
- Atlanta Oncology Associates Offers First and Only AccuBoost Breast Cancer Radiotherapy Procedure in Metro Atlanta
- Delaware Cancer Patients Among Nation's First to Benefit From Expansion of the American Cancer Society's 'Patient Navigator Program'
- Valeant Pharmaceuticals Announces Availability of Complimentary ``Managing Chemotherapy Side Effects For Dummies'' Cancer Chemotherapy Resource; Special Edition ``For Dummies''(R) Book Now Available for Cancer Chemotherapy Patients and Caregivers
- Pill Gives New Hope in Lung Cancer Fight Patients Get More Time With Loved Ones at Home
- Narrative Review: Screening for Colorectal Cancer in Patients With a First-Degree Relative With Colonic Neoplasia
 |
 |
User Comments (0)
RSS Feeds